HALO News and Press, Halozyme Therapeutics Inc. From 02/26/22

I was drawn to Halozyme due to its business model that is devoid of in-house drug development. Halozyme reformulates many blockbuster drugs that provided them with significant milestones and royalty. What is more, the impressive number of partners diversifies their revenue sources and...

The following slide deck was published by Halozyme Therapeutics, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Halozyme Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation

Halozyme Therapeutics, Inc. (HALO) Q4 2021 Earnings Conference Call February 22, 2022 4:30 P.M. ET Company Participants Al Kildani - Vice President of Investor Relations and Corporate Communications Helen Torley - President and Chief Executive Officer Nicole LaBrosse - Chief Financial Officer...

Halozyme Therapeutics press release (NASDAQ:HALO): Q4 Non-GAAP EPS of $0.42 beats by $0.01. Revenue of $102M (-16.2% Y/Y) beats by $2.31M. 2022 Revenue Guidance of $530 to $560 Million Representing 20-26% Growth over Reported 2021 Revenue. Recurring Revenue from Royalties in 2022 Expected to ...

HALOZYME REPORTS FOURTH QUARTER 2021 AND FULL YEAR RESULTS -<span class="legendSpanClass">Reports Fourth Quarter Revenue of $102.0 million with GAAP Diluted Earnings per Share of $0.46 and Non-GAAP Diluted Earnings per Share of $0.42 -</span> -<span class="leg...

HALOZYME TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL PR Newswire SAN DIEGO , Feb. 9, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the fourth ...

Halozyme Therapeutics (NASDAQ:HALO) promoted Nicole LaBrosse to the position of senior vice president and CFO, effective immediately. LaBrosse will succeed Elaine Sun, who is stepping down to pursue another opportunity. LaBrosse joined Halozyme in 2015, and since 2020 served as vice...

Halozyme Appoints New Chief Financial Officer PR Newswire SAN DIEGO , Feb. 2, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of senior vice president, chief financial...

Sony Interactive Entertainment (NYSE: SONY) , revealed plans to acquire video game developer Bungie for a total of USD3.6 Billion. Bungie, which was previously acquired by Microsoft in 2000 before parting ways, is the company behind popular video games, Destiny and Halo. ...

HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK - 2022 Revenue Guidance of $530 to $560 Million Representing 23-26% Growth over Expected 2021 Revenue - - 2022 Recurring Revenue from Royalties Projected to Grow by Approximately 50% over Record Royalties in 2021 to Appro...